The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
zi ti cik xi bao zhi liao e xing zhong liu 73 li de hu li
Author(s): 
Pages: 7256-7256
Year: Issue:  29
Journal: Chinese Journal of Misdiagnosis

Abstract:  细胞因子诱导的杀伤细胞(ytokin induced killer,CIK)是将人体PBMCS在体外经多种细胞因子培养后获得的具有非MHC限制性杀瘤活性的一群异质细胞[1].CIK细胞治疗是继LAK细胞之后的一种高效、广谱的肿瘤治疗手段,可提高肿瘤患者的细胞免疫功能,提高对肿瘤细胞的杀伤作用[2],且有较好的疗效和很好的安全性[3-5].本病区2006年至今CIK细胞治疗恶性肿瘤患者73例,护理...
Related Articles
No related articles found